- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00881010
Automated Pain Intervention for Underserved Minority Breast Cancer Patients
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The special telephone system used in this study calls patients on a regular basis and asks them to report their symptoms. The patient's doctor or nurse is notified by a page or e-mail when one or more of these symptoms is severe: pain, shortness of breath, nausea, vomiting, drowsiness, sadness, and emotional distress. Researchers want to find out if using the telephone system is a better way to manage a patient's pain and symptoms than the normal method, in which the doctor and nurse would simply ask about pain and other symptoms.
You will be asked to complete several questionnaires during a visit to the oncology clinic. These questionnaires measure pain and other symptoms, quality of life, and mood. Completing the questionnaires takes about 1 hour. These will be completed during your first study visit (called the "baseline" visit.)
If you choose to take part in this study, you will be randomly assigned (as in the toss of a coin) to receive 1 of 2 treatment plans: telephone intervention or usual care. You have an equal chance of being assigned to either group.
If you are picked to be in the "telephone intervention" group, the research nurse will teach you how to use the telephone system for measuring symptoms. The research nurse also will ask you to practice using the telephone system. The telephone system will call you 2 times a week for 10 weeks and ask you to rate your pain and other symptoms and how much the symptoms interfere with your life. You can set up the most convenient times for the telephone calls. Rating your symptoms using the telephone system takes less than 5 minutes for each call.
Your symptom information from the telephone system will be given to your doctor and nurse at M. D. Anderson. The doctor or nurse will be notified right away by page or e-mail when one or more of these symptoms is severe: pain, shortness of breath, nausea, vomiting, drowsiness, sadness, and emotional distress. Patients in this group will also receive education from the telephone system about pain and pain treatments. If for some reason the telephone system is not working, the research staff will report your severe symptoms to your doctor of nurse, and give you the education about pain and pain treatments.
If you are assigned to the "usual care" group, then you will not be asked to report symptoms using the telephone system, and your symptom information from the questionnaires will not be given to your doctor and nurse at M. D. Anderson.
No matter what group you are assigned to, you will be asked to report all symptoms to your doctor and nurse during your visits to the oncology clinic. You will also be asked to call your doctor or nurse when symptoms are severe. The doctors and nurses will give you instructions about calling when your symptoms are severe.
You will be asked to fill out questionnaires during 2 regularly-scheduled clinic visits--at the visit 4-6 weeks after the study begins and at the visit 8-10 weeks after the study begins. These questionnaires measure pain and other symptoms, quality of life, and mood. Completing the questionnaires takes about 1 hour.
If you agree to participate in the companion caregiver study, the study staff will use your demographic and clinical data to study the influence of your symptoms on your caregiver's physical and mental health.
Your total participation in this study will be up to 10 weeks.
This is an investigational study. Up to 60 patients will take part in this multicenter study. About 10 will be enrolled at M. D. Anderson.
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiesteder
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030
- University of Texas MD Anderson Cancer Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Diagnosis of breast cancer
- African American or Hispanic female
- Receiving treatment at LBJ General Hospital, Ben Taub Hospital, or M.D. Anderson Cancer Center
- Socioeconomically disadvantaged, as indicated by hospital billing code
- 18 years of age or older
- Living in the United States
- Speaks English or Spanish
- "Pain worst" score of 4 or greater on the Brief Pain Inventory
Exclusion Criteria:
- Current diagnosis of psychosis or dementia
- No access to telephones
- Unable to use the IVR system due to physical limitations (e.g., hearing impairment)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Telephone Intervention
|
Automated Telephone Interactive Voice Response (IVR) system taking approximately 5 minutes, 2 times week for 10 weeks, to rate pain and symptoms.
Surveys approximately 1 hour each at 2 regularly scheduled clinic visits to rate pain and symptoms.
Regardless of group, all symptoms are to be reported.
|
Sædvanlig pleje
|
Surveys approximately 1 hour each at 2 regularly scheduled clinic visits to rate pain and symptoms.
Regardless of group, all symptoms are to be reported.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
MDASI IVR Patient Symptom Assessment
Tidsramme: Twice weekly
|
Twice weekly
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Tito Mendoza, PHD, MS, MED, BS, M.D. Anderson Cancer Center
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2005-0380
- NCI-2012-02119 (Registry Identifier: NCI CTRP)
- RSGT-05-219-01-CPPB (Andet bevillings-/finansieringsnummer: American Cancer Society)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Brystkræft
-
Cairo UniversityIkke rekrutterer endnu
-
Abouqir General HospitalAlexandria UniversityRekrutteringBreast Udseende Rekonstruktion DisproportionEgypten
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbejdspartnereAfsluttetDen kliniske anvendelsesvejledning af Conebeam Breast CTKina
-
ETOP IBCSG Partners FoundationAfsluttetBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAfsluttetBreast Cancer Invasive NosSpanien
-
Ontario Clinical Oncology Group (OCOG)Afsluttet
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional...UkendtBRCA1 mutation | Breast Cancer Invasive NosPolen
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UkendtHR-positiv, HER2-negativ og PIK3CA Mutation Advanced Breast CancerKina
-
Aga Khan UniversityAfsluttetBrystkræft | Perforatorklap | Brysttumor | Oncoplasty | Breast-QPakistan
-
University Health Network, TorontoAfsluttetBreast Cancer Invasive Nos | Primær invasiv brystkræftCanada
Kliniske forsøg med Telephone Intervention
-
Biolux Research Holdings, Inc.AfsluttetOrtodontisk tandbevægelseCanada
-
University of FloridaAfsluttetFølsomhedForenede Stater
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Institute on Minority Health...RekrutteringHuman papillomavirus infektionForenede Stater
-
Roswell Park Cancer InstituteAfsluttetFedme | Overvægtig | Anatomisk fase I brystkræft AJCC v8 | Anatomisk fase IA brystkræft AJCC v8 | Anatomisk fase IB brystkræft AJCC v8 | Anatomisk fase II brystkræft AJCC v8 | Anatomisk fase IIA brystkræft AJCC v8 | Anatomisk fase IIB brystkræft AJCC v8 | Anatomisk fase III brystkræft AJCC v8 | Anatomisk fase... og andre forholdForenede Stater
-
Mayo ClinicAktiv, ikke rekrutterende
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityAfsluttetOndartet neoplasmaForenede Stater
-
Fred Hutchinson Cancer CenterPrevent Cancer FoundationAfsluttet
-
M.D. Anderson Cancer CenterTrukket tilbageStadie IB3 Livmoderhalskræft FIGO 2018 | Fase II Livmoderhalskræft FIGO 2018 | Fase IIA Livmoderhalskræft FIGO 2018 | Fase IIA1 Livmoderhalskræft FIGO 2018 | Fase IIA2 Livmoderhalskræft FIGO 2018 | Stadie IIB Livmoderhalskræft FIGO 2018 | Stadie III livmoderhalskræft FIGO 2018 | Fase IIIA Livmoderhalskræft... og andre forhold
-
University of South CarolinaGuangxi Zhuang Autonomous Region Center for Disease Prevention and ControlIkke rekrutterer endnuHIV/AIDS | Følelsesmæssig tilpasning | Stigma, socialForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringBiokemisk tilbagevendende prostatakarcinom | Fase IV prostatakræft AJCC v8 | Stage IVA prostatakræft AJCC v8 | Stadie IVB prostatakræft AJCC v8 | Metastatisk prostataadenokarcinomForenede Stater